表观遗传学调节剂作为神经疾病治疗的治疗方法
Mansi Gaba1, Ashwani Sharma2, Nitin Chitranshi3
1School of Pharmaceutical Sciences, MVN University, Palwal, Haryana, India.
Current pharmaceutical design
|February 14, 2025
概括
表观遗传机制影响神经系统疾病. 表观遗传疗法通过向基因表达来治疗阿尔茨海默症和帕金森症等疾病,但挑战仍然存在.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 表观遗传机制 (DNA甲基化,基因组修饰,非编码RNA) 对于基因表达和神经可塑性至关重要.
- 这些表观遗传过程的失调与诸如阿尔茨海默病,帕金森病和等神经系统疾病的发病有关.
研究的目的:
- 审查最近关于神经疾病表观遗传疗法的发现.
- 讨论在临床环境中使用表观遗传调节器的潜在好处和挑战.
主要方法:
- 审查当前临床试验和研究表观遗传调节器的研究.
- 对表观遗传机制的分析,包括DNA甲基转移酶和基因素脱乙酶抑制剂.
主要成果:
- 表观遗传调节器提供了一个有希望的策略来纠正异常的表观遗传标记,并恢复神经的平衡.
- 这些干预措施有可能阻止或逆转疾病的进展,提供有针对性和神经保护作用.
结论:
- 表观遗传疗法为治疗神经系统疾病提供了一种新的方法.
- 关键的挑战包括确保这些治疗的特异性,有效交付和长期疗效.
关键词:
通过DNA甲基化.表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.表观遗传调节器 表观遗传调节器基斯顿基因基因基因基因基因基因基因基因基因基因基因基因基因神经系统疾病 神经系统疾病治疗干预治疗干预更多相关视频
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
64
08:37Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020
3.5K
相关概念视频
Human Genetics
522
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
522
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Neurochemical Transmission: Sites of Drug Action
2.0K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
